These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 7771405

  • 21. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
    Dahlman T, Hartvig P, Löfholm M, Nordlinder H, Lööf L, Westermark K.
    QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
    [Abstract] [Full Text] [Related]

  • 22. Preparation of and clinical experiences with trien for the treatment of Wilson's disease in absolute intolerance of D-penicillamine.
    Harders H, Cohnen E.
    Proc R Soc Med; 1977 Sep; 70 Suppl 3(Suppl 3):10-2. PubMed ID: 122652
    [No Abstract] [Full Text] [Related]

  • 23. [Treatment of Wilson's disease with zinc. 5 cases].
    Bona I, Broussolle E, Neuschwander P, Confavreux C, Fontanges T, Accominotti M, Chazot G.
    Rev Neurol (Paris); 1993 Sep; 149(6-7):393-7. PubMed ID: 8303158
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
    Leinweber B, Möller JC, Scherag A, Reuner U, Günther P, Lang CJ, Schmidt HH, Schrader C, Bandmann O, Czlonkowska A, Oertel WH, Hefter H.
    Mov Disord; 2008 Jan; 23(1):54-62. PubMed ID: 17960799
    [Abstract] [Full Text] [Related]

  • 25. Treatment of Wilson's disease: penicillamine or triene?
    Kiechl SG, Willeit J, Aichner F, Felber S.
    Acta Neurol Scand; 1992 Feb; 85(2):154-7. PubMed ID: 1574992
    [No Abstract] [Full Text] [Related]

  • 26. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
    Siegemund R, Lössner J, Günther K, Kühn HJ, Bachmann H.
    Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
    [Abstract] [Full Text] [Related]

  • 27. [Wilson's disease].
    Bonfissuto G, Magliarisi C, Soresi M, Bascone F, Costanza G, Carroccio A, Montalto G.
    Recenti Prog Med; 1997 Jan; 88(1):40-5. PubMed ID: 9102715
    [Abstract] [Full Text] [Related]

  • 28. [Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
    Ritland S.
    Tidsskr Nor Laegeforen; 1987 Aug 10; 107(22):1770-1. PubMed ID: 3660361
    [No Abstract] [Full Text] [Related]

  • 29. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G, Keidl E, Hütteroth T, Dormeyer HH, Manns M, Meyer zum Büschenfelde KH.
    Z Gastroenterol; 1985 Jan 10; 23(1):25-9. PubMed ID: 4060799
    [Abstract] [Full Text] [Related]

  • 30. Neurological abnormalities in Wilson's disease are reversible.
    Lingam S, Wilson J, Nazer H, Mowat AP.
    Neuropediatrics; 1987 Feb 10; 18(1):11-2. PubMed ID: 3561699
    [Abstract] [Full Text] [Related]

  • 31. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC, Mestriner C, Irato P, Albergoni V, Longo G, D'Incà R.
    Am J Gastroenterol; 1999 Feb 10; 94(2):334-8. PubMed ID: 10022625
    [Abstract] [Full Text] [Related]

  • 32. Successful long term oral zinc in florid Wilson's disease: a case report.
    Kaur U, Bambery P, Bhushnurmath SR, Deodhar SD, Dilawari JB.
    Trop Geogr Med; 1988 Apr 10; 40(2):161-5. PubMed ID: 3407008
    [Abstract] [Full Text] [Related]

  • 33. Wilson's disease: from the liver to the brain.
    Taylor R, Dhawan A.
    Nurs Times; 1988 Apr 10; 97(30):38-40. PubMed ID: 11957950
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
    Brewer GJ, Johnson VD, Dick RD, Hedera P, Fink JK, Kluin KJ.
    Hepatology; 2000 Feb 10; 31(2):364-70. PubMed ID: 10655259
    [Abstract] [Full Text] [Related]

  • 35. Treatment of Wilson's disease.
    Deiss A.
    Ann Intern Med; 1983 Sep 10; 99(3):398-400. PubMed ID: 6614689
    [No Abstract] [Full Text] [Related]

  • 36. [Therapeutic approaches to Wilson's disease].
    Meiner Z.
    Harefuah; 1990 Mar 01; 118(5):296-8. PubMed ID: 2344986
    [No Abstract] [Full Text] [Related]

  • 37. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L, Campanella G, D'Addabbo A.
    Acta Neurol (Napoli); 1971 Mar 01; 26(4):423-35. PubMed ID: 5132824
    [No Abstract] [Full Text] [Related]

  • 38. Two male patients with Wilson's disease treated using trientine and iron reduction therapy.
    Hayashi H, Ueno T, Yano M, Okada T, Mabuchi H.
    J Gastroenterol Hepatol; 2005 Oct 01; 20(10):1627-8. PubMed ID: 16174091
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of Wilson's disease: in D-penicillamine we trust--what about zinc?
    Lipsky MA, Gollan JL.
    Hepatology; 1987 Oct 01; 7(3):593-5. PubMed ID: 3570170
    [No Abstract] [Full Text] [Related]

  • 40. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V, Di Leo V, Lamboglia F, Bowlus CL, Tseng SC, D'Incà R, Irato P, Burra P, Martines D, Sturniolo GC.
    Scand J Gastroenterol; 2007 Dec 01; 42(12):1495-500. PubMed ID: 17994470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.